3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
7
OTHER
2
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
1
Interventions
Specimen Handling
19
Magnetic Resonance Spectroscopy
15
Dexamethasone
9
Vincristine
7
Radiation
7
Cyclophosphamide
7
daratumumab
6
Radiotherapy
6
Leucovorin
6
Lenalidomide
6
Cisplatin
6
Calcium Dobesilate
6
durvalumab
5
dexamethasone acetate
5
dexamethasone 21-phosphate
5
auricularum
5
Standard of Care
5
Radiotherapy, Conformal
5
Radiosurgery
5
Practice Guidelines as Topic
5
Gemcitabine
5
Doxorubicin
5
Bortezomib
5
Radiotherapy, Intensity-Modulated
4
Paclitaxel
4
Fluorouracil
4
Etoposide
4
Biopsy
4
X-Rays
3
Taxes
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
trifluridine tipiracil drug combination
×
30 days
×
Clear all
NCT04489173
2026-05-22
TIBET
Borstkanker Onderzoek Groep
Phase 2
Completed
52 enrolled